Hangzhou Alltest Biotech Co., Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CNY 3,451.7 million compared to CNY 1,873.43 million a year ago. Net income was CNY 1,299.63 million compared to CNY 765.69 million a year ago.

Basic earnings per share from continuing operations was CNY 16.2905 compared to CNY 10.2365 a year ago.